A blood pressure medication has been recalled by the U.S. Food and Drug Administration due to its potential cancer risk resulting from contamination.
The drug, irbesartan from certain lots is being recalled after tests showed NDEA or N-Nitrosodiethylamine was found within the medication. NDEA is considered to be a carcinogen by the National Institutes of Health and is frequently used as an additive in gasoline and lubricants.
While the recalled drugs are products of ScieGen Pharmaceuticals, they will be labeled under both Westminster Pharmaceuticals and GSMS Incorporated.
Click here to view the recalled irbesartan drugs. This recall only affects certain types of irbesartan and only affects around one percent of the drugs within the U.S.
Irbesartan is the first drug that does not contain valsartan that is known to contain NDEA.
Valsartan is an ingredient known to help with heart failure and high blood pressure.
Click here for a full list of valsartan products that have been recalled.
Click here for a full list of valsartan products that are not recalled.